{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T03:27:42Z","timestamp":1793158062663,"version":"4.5.0"},"reference-count":71,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T00:00:00Z","timestamp":1762473600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T00:00:00Z","timestamp":1762473600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100004543","name":"China Scholarship Council","doi-asserted-by":"publisher","award":["201808360194"],"award-info":[{"award-number":["201808360194"]}],"id":[{"id":"10.13039\/501100004543","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003130","name":"Fonds Wetenschappelijk Onderzoek","doi-asserted-by":"publisher","award":["1157621N"],"award-info":[{"award-number":["1157621N"]}],"id":[{"id":"10.13039\/501100003130","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003130","name":"Fonds Wetenschappelijk Onderzoek","doi-asserted-by":"publisher","award":["1195021N"],"award-info":[{"award-number":["1195021N"]}],"id":[{"id":"10.13039\/501100003130","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003130","name":"Fonds Wetenschappelijk Onderzoek","doi-asserted-by":"publisher","award":["1295223N"],"award-info":[{"award-number":["1295223N"]}],"id":[{"id":"10.13039\/501100003130","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003130","name":"Fonds Wetenschappelijk Onderzoek","doi-asserted-by":"publisher","award":["1268823N"],"award-info":[{"award-number":["1268823N"]}],"id":[{"id":"10.13039\/501100003130","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010563","name":"Fonds Baillet Latour","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100010563","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006401","name":"Fondation Charcot","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006401","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Fluids Barriers CNS"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Multiple sclerosis (MS) is a chronic inflammatory disease that has been associated with dysfunction of the protective barriers in the central nervous system (CNS), allowing harmful immune cells to enter. Growing evidence implicates gut microbiota dysbiosis in MS pathogenesis, yet its connection to CNS barrier integrity is not fully understood. To address this, we investigated the role of gut microbiota in experimental autoimmune encephalomyelitis (EAE), a mouse model of MS, by depleting intestinal microbes using a broad-spectrum antibiotic (ABX) regimen. Our results indicate that ABX-mediated gut microbiota depletion was associated with a milder EAE disease course, accompanied by reduced immune cell infiltration and attenuation of EAE-associated loss of barrier integrity. These improvements coincided with preserved expression and localization of tight junction (TJ) proteins, vital for maintaining barrier integrity. While these data support a microbiota-mediated effect, ABX compounds may also exert microbiota-independent immunomodulatory actions. Importantly, although ABX treatment proved beneficial in the inflammatory EAE setting, antibiotics are also known to disrupt immune and barrier homeostasis under steady-state conditions, highlighting their dual and context-dependent nature. To further look into this, we transferred gut microbiota between EAE and healthy mice and observed a microbiota-dependent effect on CNS barrier integrity. Next, treatment with SCFAs partly restored the disrupted CNS barriers and was linked to reduced disease development in EAE. Altogether, our findings suggest that the gut microbiota has dual role in the CNS barriers in MS. These findings align with emerging literature identifying gut-derived signals, particularly under antibiotic perturbation or through microbial metabolites, as critical modulators of neuroimmune homeostasis. Additionally, our results highlight the potential of microbiota-targeted interventions and SCFAs to influence CNS barrier integrity and disease outcomes.<\/jats:p>","DOI":"10.1186\/s12987-025-00724-y","type":"journal-article","created":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T13:05:06Z","timestamp":1762520706000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Gut microbiota modulates CNS barrier function in murine model for multiple sclerosis"],"prefix":"10.1186","volume":"22","author":[{"given":"Junhua","family":"Xie","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marlies","family":"Burgelman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pieter","family":"Dujardin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonas","family":"Castelein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Griet","family":"Van Imschoot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elien","family":"Van Wonterghem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hannah","family":"Lernout","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sjoerd T. T.","family":"Schetters","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charysse","family":"Vandendriessche","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lien","family":"Van Hoecke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roosmarijn E.","family":"Vandenbroucke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,7]]},"reference":[{"issue":"4","key":"724_CR1","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1016\/j.neuron.2018.01.021","volume":"97","author":"C Baecher-Allan","year":"2018","unstructured":"Baecher-Allan C, Kaskow BJ, Weiner HL. Multiple sclerosis: mechanisms and immunotherapy. Neuron. 2018;97(4):742\u201368. https:\/\/doi.org\/10.1016\/j.neuron.2018.01.021.","journal-title":"Neuron"},{"issue":"9","key":"724_CR2","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1038\/nri3871","volume":"15","author":"CA Dendrou","year":"2015","unstructured":"Dendrou CA, Fugger L, Friese MA. Immunopathology of multiple sclerosis. Nat Rev Immunol. 2015;15(9):545\u201358. https:\/\/doi.org\/10.1038\/nri3871.","journal-title":"Nat Rev Immunol"},{"issue":"6","key":"724_CR3","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1002\/eji.202149757","volume":"52","author":"B Engelhardt","year":"2022","unstructured":"Engelhardt B, Comabella M, Chan A. Multiple sclerosis: immunopathological heterogeneity and its implications. Eur J Immunol. 2022;52(6):869\u201381. https:\/\/doi.org\/10.1002\/eji.202149757.","journal-title":"Eur J Immunol"},{"key":"724_CR4","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1007\/164_2020_407","volume":"273","author":"H Nishihara","year":"2022","unstructured":"Nishihara H, Engelhardt B. Brain barriers and multiple sclerosis: novel treatment approaches from a brain barriers perspective. Handb Exp Pharmacol. 2022;273:295\u2013329. https:\/\/doi.org\/10.1007\/164_2020_407.","journal-title":"Handb Exp Pharmacol"},{"key":"724_CR5","doi-asserted-by":"publisher","unstructured":"Palmer AM. Multiple sclerosis and the blood-central nervous system barrier. Cardiovasc Psychiatry Neurol. 2013, 2013, 530356. https:\/\/doi.org\/10.1155\/2013\/530356.","DOI":"10.1155\/2013\/530356"},{"issue":"7","key":"724_CR6","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1038\/nri1130","volume":"3","author":"RM Ransohoff","year":"2003","unstructured":"Ransohoff RM, Kivisakk P, Kidd G. Three or more routes for leukocyte migration into the central nervous system. Nat Rev Immunol. 2003;3(7):569\u201381. https:\/\/doi.org\/10.1038\/nri1130.","journal-title":"Nat Rev Immunol"},{"issue":"1","key":"724_CR7","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/2045-8118-8-3","volume":"8","author":"Z Redzic","year":"2011","unstructured":"Redzic Z. Molecular biology of the blood-brain and the blood-cerebrospinal fluid barriers: similarities and differences. Fluids Barriers CNS. 2011;8(1):3. https:\/\/doi.org\/10.1186\/2045-8118-8-3.","journal-title":"Fluids Barriers CNS"},{"issue":"2","key":"724_CR8","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1002\/ana.22421","volume":"70","author":"V Bartanusz","year":"2011","unstructured":"Bartanusz V, Jezova D, Alajajian B, Digicaylioglu M. The blood-spinal cord barrier: morphology and clinical implications. Ann Neurol. 2011;70(2):194\u2013206. https:\/\/doi.org\/10.1002\/ana.22421.","journal-title":"Ann Neurol"},{"issue":"1","key":"724_CR9","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1186\/s12987-023-00429-0","volume":"20","author":"RF Keep","year":"2023","unstructured":"Keep RF, Jones HC, Hamilton MG, Drewes LR. A year in review: brain barriers and brain fluids research in 2022. Fluids Barriers CNS. 2023;20(1):30. https:\/\/doi.org\/10.1186\/s12987-023-00429-0.","journal-title":"Fluids Barriers CNS"},{"key":"724_CR10","doi-asserted-by":"publisher","unstructured":"Schreiner TG, Romanescu C, Popescu BO. The blood-brain barrier-a key player in multiple sclerosis disease mechanisms. Biomolecules. 2022;12(4). https:\/\/doi.org\/10.3390\/biom12040538.","DOI":"10.3390\/biom12040538"},{"key":"724_CR11","doi-asserted-by":"publisher","unstructured":"Braniste V, Al-Asmakh M, Kowal C, Anuar F, Abbaspour A, Toth M, Korecka A, Bakocevic N, Ng LG, Kundu P, et al. The gut microbiota influences blood-brain barrier permeability in mice. Sci Transl Med. 2014;6(263). ARTN 263ra158. https:\/\/doi.org\/10.1126\/scitranslmed.3009759.","DOI":"10.1126\/scitranslmed.3009759"},{"key":"724_CR12","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1016\/j.bbi.2016.02.020","volume":"56","author":"EE Frohlich","year":"2016","unstructured":"Frohlich EE, Farzi A, Mayerhofer R, Reichmann F, Jacan A, Wagner B, Zinser E, Bordag N, Magnes C, Frohlich E, et al. Cognitive impairment by antibiotic-induced gut dysbiosis: analysis of gut microbiota-brain communication. Brain Behav Immun. 2016;56:140\u201355. https:\/\/doi.org\/10.1016\/j.bbi.2016.02.020.","journal-title":"Brain Behav Immun"},{"issue":"2","key":"724_CR13","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1111\/ejn.15878","volume":"57","author":"EG Knox","year":"2023","unstructured":"Knox EG, Lynch CMK, Lee YS, O\u2019Driscoll CM, Clarke G, Cryan JF, Aburto MR. The gut microbiota is important for the maintenance of blood-cerebrospinal fluid barrier integrity. Eur J Neurosci. 2023;57(2):233\u201341. https:\/\/doi.org\/10.1111\/ejn.15878.","journal-title":"Eur J Neurosci"},{"key":"724_CR14","doi-asserted-by":"publisher","unstructured":"Xie J, Bruggeman A, De Nolf C, Vandendriessche C, Van Imschoot G, Van Wonterghem E, Vereecke L, Vandenbroucke RE. Gut microbiota regulates blood-cerebrospinal fluid barrier function and abeta pathology. EMBO J. 2023;e111515. https:\/\/doi.org\/10.15252\/embj.2022111515.","DOI":"10.15252\/embj.2022111515"},{"issue":"1","key":"724_CR15","doi-asserted-by":"publisher","first-page":"2892","DOI":"10.1038\/s41598-023-29894-1","volume":"13","author":"S Sugiyama","year":"2023","unstructured":"Sugiyama S, Sasaki T, Tanaka H, Yan H, Ikegami T, Kanki H, Nishiyama K, Beck G, Gon Y, Okazaki S, et al. The tight junction protein occludin modulates blood-brain barrier integrity and neurological function after ischemic stroke in mice. Sci Rep. 2023;13(1):2892. https:\/\/doi.org\/10.1038\/s41598-023-29894-1. From NLM Medline.","journal-title":"Sci Rep"},{"issue":"9","key":"724_CR16","doi-asserted-by":"publisher","first-page":"2681","DOI":"10.1016\/j.ymthe.2023.06.011","volume":"31","author":"CM Vaswani","year":"2023","unstructured":"Vaswani CM, Varkouhi AK, Gupta S, Ektesabi AM, Tsoporis JN, Yousef S, Plant PJ, da Silva AL, Cen Y, Tseng YC, et al. Preventing occludin tight-junction disruption via Inhibition of microRNA-193b-5p attenuates viral load and influenza-induced lung injury. Mol Ther. 2023;31(9):2681\u2013701. https:\/\/doi.org\/10.1016\/j.ymthe.2023.06.011. From NLM Medline.","journal-title":"Mol Ther"},{"key":"724_CR17","doi-asserted-by":"publisher","unstructured":"Ghezzi L, Cantoni C, Pinget GV, Zhou Y, Piccio L. Targeting the gut to treat multiple sclerosis. J Clin Invest. 2021;131(13). https:\/\/doi.org\/10.1172\/JCI143774.","DOI":"10.1172\/JCI143774"},{"key":"724_CR18","doi-asserted-by":"publisher","unstructured":"Chen J, Chia N, Kalari KR, Yao JZ, Novotna M, Soldan MMP, Luckey DH, Marietta EV, Jeraldo PR, Chen XF, et al. Multiple sclerosis patients have a distinct gut microbiota compared to healthy controls. Sci Rep-Uk. 2016;6. ARTN 28484 https:\/\/doi.org\/10.1038\/srep28484.","DOI":"10.1038\/srep28484"},{"key":"724_CR19","doi-asserted-by":"publisher","unstructured":"Jangi S, Gandhi R, Cox LM, Li N, von Glehn F, Yan R, Patel B, Mazzola MA, Liu SR, Glanz BL, et al. Alterations of the human gut microbiome in multiple sclerosis. Nature Communications. 2016;7. ARTN 12015 https:\/\/doi.org\/10.1038\/ncomms12015.","DOI":"10.1038\/ncomms12015"},{"key":"724_CR20","doi-asserted-by":"publisher","unstructured":"Johanson DM, Goertz JE, Marin IA, Costello J, Overall CC, Gaultier A. Experimental autoimmune encephalomyelitis is associated with changes of the microbiota composition in the gastrointestinal tract. Sci Rep-Uk. 2020;10(1). ARTN 15183 https:\/\/doi.org\/10.1038\/s41598-020-72197-y.","DOI":"10.1038\/s41598-020-72197-y"},{"issue":"6","key":"724_CR21","doi-asserted-by":"publisher","first-page":"1714","DOI":"10.2353\/ajpath.2008.080622","volume":"173","author":"H Yokote","year":"2008","unstructured":"Yokote H, Miyake S, Croxford JL, Oki S, Mizusawa H, Yamamura T. NKT cell-dependent amelioration of a mouse model of multiple sclerosis by altering gut flora. Am J Pathol. 2008;173(6):1714\u201323. https:\/\/doi.org\/10.2353\/ajpath.2008.080622. From NLM Medline.","journal-title":"Am J Pathol"},{"issue":"2","key":"724_CR22","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1016\/j.smim.2011.01.010","volume":"23","author":"K Atarashi","year":"2011","unstructured":"Atarashi K, Umesaki Y, Honda K. Microbiotal influence on T cell subset development. Semin Immunol. 2011;23(2):146\u201353. https:\/\/doi.org\/10.1016\/j.smim.2011.01.010. From NLM Medline.","journal-title":"Semin Immunol"},{"issue":"6","key":"724_CR23","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1016\/j.coi.2011.11.002","volume":"23","author":"K Atarashi","year":"2011","unstructured":"Atarashi K, Honda K. Microbiota in autoimmunity and tolerance. Curr Opin Immunol. 2011;23(6):761\u20138. From NLM Medline.","journal-title":"Curr Opin Immunol"},{"issue":"1","key":"724_CR24","doi-asserted-by":"publisher","first-page":"918","DOI":"10.1038\/s41598-018-37505-7","volume":"9","author":"S Stanisavljevic","year":"2019","unstructured":"Stanisavljevic S, Cepic A, Bojic S, Veljovic K, Mihajlovic S, Dedovic N, Jevtic B, Momcilovic M, Lazarevic M, Mostarica Stojkovic M, et al. Oral neonatal antibiotic treatment perturbs gut microbiota and aggravates central nervous system autoimmunity in dark Agouti rats. Sci Rep. 2019;9(1):918. https:\/\/doi.org\/10.1038\/s41598-018-37505-7. From NLM Medline.","journal-title":"Sci Rep"},{"issue":"2","key":"724_CR25","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1053\/j.gastro.2011.04.052","volume":"141","author":"P Bercik","year":"2011","unstructured":"Bercik P, Denou E, Collins J, Jackson W, Lu J, Jury J, Deng Y, Blennerhassett P, Macri J, McCoy KD, et al. The intestinal microbiota affect central levels of brain-derived neurotropic factor and behavior in mice. Gastroenterology. 2011;141(2):599\u2013609. https:\/\/doi.org\/10.1053\/j.gastro.2011.04.052.","journal-title":"Gastroenterology"},{"issue":"2","key":"724_CR26","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1080\/19490976.2019.1638722","volume":"11","author":"A Parker","year":"2020","unstructured":"Parker A, Fonseca S, Carding SR. Gut microbes and metabolites as modulators of blood-brain barrier integrity and brain health. Gut Microbes. 2020;11(2):135\u201357. https:\/\/doi.org\/10.1080\/19490976.2019.1638722.","journal-title":"Gut Microbes"},{"issue":"1","key":"724_CR27","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1186\/s40168-018-0439-y","volume":"6","author":"L Hoyles","year":"2018","unstructured":"Hoyles L, Snelling T, Umlai UK, Nicholson JK, Carding SR, Glen RC, McArthur S. Microbiome-host systems interactions: protective effects of propionate upon the blood-brain barrier. Microbiome. 2018;6(1):55. https:\/\/doi.org\/10.1186\/s40168-018-0439-y.","journal-title":"Microbiome"},{"key":"724_CR28","doi-asserted-by":"publisher","unstructured":"Macfabe DF. Short-chain fatty acid fermentation products of the gut microbiome: implications in autism spectrum disorders. Microb Ecol Health Dis. 2012;23. https:\/\/doi.org\/10.3402\/mehd.v23i0.19260.","DOI":"10.3402\/mehd.v23i0.19260"},{"issue":"24","key":"724_CR29","doi-asserted-by":"publisher","first-page":"5744","DOI":"10.1111\/bph.13348","volume":"172","author":"SP Alexander","year":"2015","unstructured":"Alexander SP, Davenport AP, Kelly E, Marrion N, Peters JA, Benson HE, Faccenda E, Pawson AJ, Sharman JL, Southan C, et al. The concise guide to PHARMACOLOGY 2015\/16: G protein-coupled receptors. Br J Pharmacol. 2015;172(24):5744\u2013869. https:\/\/doi.org\/10.1111\/bph.13348.","journal-title":"Br J Pharmacol"},{"key":"724_CR30","doi-asserted-by":"publisher","unstructured":"Miyake S, Kim S, Suda W, Oshima K, Nakamura M, Matsuoka T, Chihara N, Tomita A, Sato W, Kim SW, et al. Dysbiosis in the gut microbiota of patients with multiple sclerosis, with a striking depletion of species belonging to clostridia XIVa and IV clusters. PLoS One. 2015;10(9):e0137429. https:\/\/doi.org\/10.1371\/journal.pone.0137429.","DOI":"10.1371\/journal.pone.0137429"},{"issue":"8","key":"724_CR31","doi-asserted-by":"publisher","first-page":"1308","DOI":"10.1111\/ene.13026","volume":"23","author":"H Tremlett","year":"2016","unstructured":"Tremlett H, Fadrosh DW, Faruqi AA, Zhu F, Hart J, Roalstad S, Graves J, Lynch S, Waubant E, Centers USN. o. P. M. Gut microbiota in early pediatric multiple sclerosis: a case-control study. Eur J Neurol. 2016;23(8):1308\u201321. https:\/\/doi.org\/10.1111\/ene.13026. From NLM Medline.","journal-title":"Eur J Neurol"},{"issue":"1","key":"724_CR32","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1186\/s12883-016-0703-3","volume":"16","author":"H Tremlett","year":"2016","unstructured":"Tremlett H, Fadrosh DW, Faruqi AA, Hart J, Roalstad S, Graves J, Spencer CM, Lynch SV, Zamvil SS, Waubant E, Centers USN. o. P. M. Associations between the gut microbiota and host immune markers in pediatric multiple sclerosis and controls. BMC Neurol. 2016;16(1):182. https:\/\/doi.org\/10.1186\/s12883-016-0703-3. From NLM Publisher.","journal-title":"BMC Neurol"},{"issue":"6","key":"724_CR33","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.1016\/j.cell.2020.02.035","volume":"180","author":"A Duscha","year":"2020","unstructured":"Duscha A, Gisevius B, Hirschberg S, Yissachar N, Stangl GI, Eilers E, Bader V, Haase S, Kaisler J, David C, et al. Propionic acid shapes the multiple sclerosis disease course by an Immunomodulatory mechanism. Cell. 2020;180(6):1067\u2013e10801016. https:\/\/doi.org\/10.1016\/j.cell.2020.02.035.","journal-title":"Cell"},{"key":"724_CR34","doi-asserted-by":"publisher","unstructured":"Ghezzi L, Cantoni C, Pinget GV, Zhou YJ, Piccio L. Targeting the gut to treat multiple sclerosis. J Clin Invest. 2021;131(13). ARTN e143774. https:\/\/doi.org\/10.1172\/JCI143774.","DOI":"10.1172\/JCI143774"},{"issue":"17","key":"724_CR35","doi-asserted-by":"publisher","first-page":"e111515","DOI":"10.15252\/embj.2022111515","volume":"42","author":"J Xie","year":"2023","unstructured":"Xie J, Bruggeman A, De Nolf C, Vandendriessche C, Van Imschoot G, Van Wonterghem E, Vereecke L, Vandenbroucke RE. Gut microbiota regulates blood-cerebrospinal fluid barrier function and Abeta pathology. EMBO J. 2023;42(17):e111515. https:\/\/doi.org\/10.15252\/embj.2022111515. From NLM Medline.","journal-title":"EMBO J"},{"issue":"5","key":"724_CR36","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1038\/s41419-022-04888-5","volume":"13","author":"Y Luo","year":"2022","unstructured":"Luo Y, Yang H, Wan Y, Yang S, Wu J, Chen S, Li Y, Jin H, He Q, Zhu DY, et al. Endothelial ETS1 Inhibition exacerbate blood-brain barrier dysfunction in multiple sclerosis through inducing endothelial-to-mesenchymal transition. Cell Death Dis. 2022;13(5):462. https:\/\/doi.org\/10.1038\/s41419-022-04888-5.","journal-title":"Cell Death Dis"},{"issue":"5","key":"724_CR37","doi-asserted-by":"publisher","first-page":"2173","DOI":"10.1152\/jn.00510.2016","volume":"116","author":"D Wang","year":"2016","unstructured":"Wang D, Li SP, Fu JS, Zhang S, Bai L, Guo L. Resveratrol defends blood-brain barrier integrity in experimental autoimmune encephalomyelitis mice. J Neurophysiol. 2016;116(5):2173\u20139. https:\/\/doi.org\/10.1152\/jn.00510.2016.","journal-title":"J Neurophysiol"},{"issue":"8","key":"724_CR38","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1038\/s41575-019-0157-3","volume":"16","author":"B Dalile","year":"2019","unstructured":"Dalile B, Van Oudenhove L, Vervliet B, Verbeke K. The role of short-chain fatty acids in microbiota-gut-brain communication. Nat Rev Gastroenterol Hepatol. 2019;16(8):461\u201378. https:\/\/doi.org\/10.1038\/s41575-019-0157-3.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"263","key":"724_CR39","doi-asserted-by":"publisher","first-page":"263ra158","DOI":"10.1126\/scitranslmed.3009759","volume":"6","author":"V Braniste","year":"2014","unstructured":"Braniste V, Al-Asmakh M, Kowal C, Anuar F, Abbaspour A, Toth M, Korecka A, Bakocevic N, Ng LG, Kundu P, et al. The gut microbiota influences blood-brain barrier permeability in mice. Sci Transl Med. 2014;6(263):263ra158. https:\/\/doi.org\/10.1126\/scitranslmed.3009759.","journal-title":"Sci Transl Med"},{"key":"724_CR40","doi-asserted-by":"publisher","first-page":"114763","DOI":"10.1016\/j.biopha.2023.114763","volume":"163","author":"F Golpour","year":"2023","unstructured":"Golpour F, Abbasi-Alaei M, Babaei F, Mirzababaei M, Parvardeh S, Mohammadi G, Nassiri-Asl M. Short chain fatty acids, a possible treatment option for autoimmune diseases. Biomed Pharmacother. 2023;163:114763. https:\/\/doi.org\/10.1016\/j.biopha.2023.114763.","journal-title":"Biomed Pharmacother"},{"issue":"1","key":"724_CR41","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/s13317-021-00149-1","volume":"12","author":"A Becker","year":"2021","unstructured":"Becker A, Abuazab M, Schwiertz A, Walter S, Fassbender KC, Fousse M, Unger MM. Short-chain fatty acids and intestinal inflammation in multiple sclerosis: modulation of female susceptibility by microbial products? Auto Immun Highlights. 2021;12(1):7. https:\/\/doi.org\/10.1186\/s13317-021-00149-1.","journal-title":"Auto Immun Highlights"},{"key":"724_CR42","doi-asserted-by":"publisher","unstructured":"Kadry H, Noorani B, Cucullo L. A blood-brain barrier overview on structure, function, impairment, and biomarkers of integrity. Fluids Barriers Cns. 2020;17(1). https:\/\/doi.org\/10.1186\/s12987-020-00230-3.","DOI":"10.1186\/s12987-020-00230-3"},{"issue":"1","key":"724_CR43","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1186\/s40478-021-01253-z","volume":"9","author":"J Xie","year":"2021","unstructured":"Xie J, Gorl\u00e9 N, Vandendriessche C, Van Imschoot G, Van Wonterghem E, Van Cauwenberghe C, Parthoens E, Van Hamme E, Lippens S, Van Hoecke L, Vandenbroucke RE. Low-grade peripheral inflammation affects brain pathology in the AppNL-G-F mouse model of alzheimer\u2019s disease. Acta Neuropathol Commun. 2021;9(1):163. https:\/\/doi.org\/10.1186\/s40478-021-01253-z.","journal-title":"Acta Neuropathol Commun"},{"key":"724_CR44","doi-asserted-by":"publisher","unstructured":"Fabis MJ, Scott GS, Kean RB, Koprowski H, Hooper DC. Loss of blood-brain barrier integrity in the spinal cord is common to experimental allergic encephalomyelitis in knockout mouse models. Proc Natl Acad Sci USA. 2007;104(13):5656\u2013661. https:\/\/doi.org\/10.1073\/pnas.0701252104.","DOI":"10.1073\/pnas.0701252104"},{"key":"724_CR45","doi-asserted-by":"publisher","first-page":"593026","DOI":"10.3389\/fphys.2020.593026","volume":"11","author":"S Al-Bachari","year":"2020","unstructured":"Al-Bachari S, Naish JH, Parker GJM, Emsley HCA, Parkes LM. Blood-brain barrier leakage is increased in parkinson\u2019s disease. Front Physiol. 2020;11:593026. https:\/\/doi.org\/10.3389\/fphys.2020.593026.","journal-title":"Front Physiol"},{"issue":"2","key":"724_CR46","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1016\/j.bbadis.2010.06.017","volume":"1812","author":"JI Alvarez","year":"2011","unstructured":"Alvarez JI, Cayrol R, Prat A. Disruption of central nervous system barriers in multiple sclerosis. Biochim Biophys Acta. 2011;1812(2):252\u201364. https:\/\/doi.org\/10.1016\/j.bbadis.2010.06.017.","journal-title":"Biochim Biophys Acta"},{"issue":"5","key":"724_CR47","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1002\/ibd.20077","volume":"13","author":"G Lahat","year":"2007","unstructured":"Lahat G, Halperin D, Barazovsky E, Shalit I, Rabau M, Klausner J, Fabian I. Immunomodulatory effects of Ciprofloxacin in TNBS-induced colitis in mice. Inflamm Bowel Dis. 2007;13(5):557\u201365. https:\/\/doi.org\/10.1002\/ibd.20077. From NLM Medline.","journal-title":"Inflamm Bowel Dis"},{"issue":"7374","key":"724_CR48","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1038\/nature10554","volume":"479","author":"K Berer","year":"2011","unstructured":"Berer K, Mues M, Koutrolos M, Rasbi ZA, Boziki M, Johner C, Wekerle H, Krishnamoorthy G. Commensal microbiota and Myelin autoantigen cooperate to trigger autoimmune demyelination. Nature. 2011;479(7374):538\u201341. https:\/\/doi.org\/10.1038\/nature10554.","journal-title":"Nature"},{"issue":"7823","key":"724_CR49","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1038\/s41586-020-2634-9","volume":"585","author":"E Miyauchi","year":"2020","unstructured":"Miyauchi E, Kim SW, Suda W, Kawasumi M, Onawa S, Taguchi-Atarashi N, Morita H, Taylor TD, Hattori M, Ohno H. Gut microorganisms act together to exacerbate inflammation in spinal cords. Nature. 2020;585(7823):102\u20136. https:\/\/doi.org\/10.1038\/s41586-020-2634-9.","journal-title":"Nature"},{"issue":"10","key":"724_CR50","doi-asserted-by":"publisher","first-page":"6041","DOI":"10.4049\/jimmunol.0900747","volume":"183","author":"J Ochoa-Reparaz","year":"2009","unstructured":"Ochoa-Reparaz J, Mielcarz DW, Ditrio LE, Burroughs AR, Foureau DM, Haque-Begum S, Kasper LH. Role of gut commensal microflora in the development of experimental autoimmune encephalomyelitis. J Immunol. 2009;183(10):6041\u201350. https:\/\/doi.org\/10.4049\/jimmunol.0900747.","journal-title":"J Immunol"},{"key":"724_CR51","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/j.bbi.2020.11.032","volume":"92","author":"N Sun","year":"2021","unstructured":"Sun N, Hu H, Wang F, Li L, Zhu W, Shen Y, Xiu J, Xu Q. Antibiotic-induced Microbiome depletion in adult mice disrupts blood-brain barrier and facilitates brain infiltration of monocytes after bone-marrow transplantation. Brain Behav Immun. 2021;92:102\u201314. https:\/\/doi.org\/10.1016\/j.bbi.2020.11.032.","journal-title":"Brain Behav Immun"},{"issue":"1","key":"724_CR52","doi-asserted-by":"publisher","first-page":"6923","DOI":"10.1038\/s41598-019-43356-7","volume":"9","author":"KAO Gandy","year":"2019","unstructured":"Gandy KAO, Zhang J, Nagarkatti P, Nagarkatti M. The role of gut microbiota in shaping the relapse-remitting and chronic-progressive forms of multiple sclerosis in mouse models. Sci Rep. 2019;9(1):6923. https:\/\/doi.org\/10.1038\/s41598-019-43356-7.","journal-title":"Sci Rep"},{"issue":"5","key":"724_CR53","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1021\/acschemneuro.0c00695","volume":"12","author":"L Moles","year":"2021","unstructured":"Moles L, Egimendia A, Osorio-Querejeta I, Iparraguirre L, Alberro A, Suarez J, Sepulveda L, Castillo-Trivino T, Munoz-Culla M, Ramos-Cabrer P, Otaegui D. Gut microbiota changes in experimental autoimmune encephalomyelitis and Cuprizone mice models. ACS Chem Neurosci. 2021;12(5):893\u2013905. https:\/\/doi.org\/10.1021\/acschemneuro.0c00695.","journal-title":"ACS Chem Neurosci"},{"issue":"9","key":"724_CR54","doi-asserted-by":"publisher","first-page":"1905","DOI":"10.1002\/acn3.50862","volume":"6","author":"E Waubant","year":"2019","unstructured":"Waubant E, Lucas R, Mowry E, Graves J, Olsson T, Alfredsson L, Langer-Gould A. Environmental and genetic risk factors for MS: an integrated review. Ann Clin Transl Neurol. 2019;6(9):1905\u201322. https:\/\/doi.org\/10.1002\/acn3.50862.","journal-title":"Ann Clin Transl Neurol"},{"issue":"40","key":"724_CR55","doi-asserted-by":"publisher","first-page":"10713","DOI":"10.1073\/pnas.1711235114","volume":"114","author":"E Cekanaviciute","year":"2017","unstructured":"Cekanaviciute E, Yoo BB, Runia TF, Debelius JW, Singh S, Nelson CA, Kanner R, Bencosme Y, Lee YK, Hauser SL, et al. Gut bacteria from multiple sclerosis patients modulate human T cells and exacerbate symptoms in mouse models. Proc Natl Acad Sci U S A. 2017;114(40):10713\u20138. https:\/\/doi.org\/10.1073\/pnas.1711235114.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"(19)","key":"724_CR56","doi-asserted-by":"publisher","first-page":"3467","DOI":"10.1016\/j.cell.2022.08.021","volume":"185","author":"MCE a.s.b.u.e","year":"2022","unstructured":"Zhou X, Baumann R, Gao X, Mendoza M, Singh S, Sand IK, Xia Z, Cox LM, Chitnis T, Yoon H, Moles L. Gut microbiome of multiple sclerosis patients and paired household healthy controls reveal associations with disease risk and course. Cell. 2022;185(19):3467-86 e3416. https:\/\/doi.org\/10.1016\/j.cell.2022.08.021.","journal-title":"Cell"},{"key":"724_CR57","doi-asserted-by":"publisher","unstructured":"Wang S, Chen H, Wen X, Mu J, Sun M, Song X, Liu B, Chen J, Fan X. The efficacy of fecal microbiota transplantation in experimental autoimmune encephalomyelitis: transcriptome and gut microbiota profiling. J Immunol Res. 2021;2021(4400428). https:\/\/doi.org\/10.1155\/2021\/4400428.","DOI":"10.1155\/2021\/4400428"},{"issue":"9","key":"724_CR58","doi-asserted-by":"publisher","first-page":"e106335","DOI":"10.1371\/journal.pone.0106335","volume":"9","author":"M Nouri","year":"2014","unstructured":"Nouri M, Bredberg A, Westrom B, Lavasani S. Intestinal barrier dysfunction develops at the onset of experimental autoimmune encephalomyelitis, and can be induced by adoptive transfer of auto-reactive T cells. PLoS ONE. 2014;9(9):e106335. https:\/\/doi.org\/10.1371\/journal.pone.0106335.","journal-title":"PLoS ONE"},{"issue":"3","key":"724_CR59","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1177\/1352458516652498","volume":"23","author":"MC Buscarinu","year":"2017","unstructured":"Buscarinu MC, Cerasoli B, Annibali V, Policano C, Lionetto L, Capi M, Mechelli R, Romano S, Fornasiero A, Mattei G, et al. Altered intestinal permeability in patients with relapsing-remitting multiple sclerosis: A pilot study. Mult Scler. 2017;23(3):442\u20136. https:\/\/doi.org\/10.1177\/1352458516652498.","journal-title":"Mult Scler"},{"issue":"2","key":"724_CR60","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/j.clim.2013.05.012","volume":"148","author":"B Teixeira","year":"2013","unstructured":"Teixeira B, Bittencourt VC, Ferreira TB, Kasahara TM, Barros PO, Alvarenga R, Hygino J, Andrade RM, Andrade AF, Bento CA. Low sensitivity to glucocorticoid Inhibition of in vitro Th17-related cytokine production in multiple sclerosis patients is related to elevated plasma lipopolysaccharide levels. Clin Immunol. 2013;148(2):209\u201318. https:\/\/doi.org\/10.1016\/j.clim.2013.05.012.","journal-title":"Clin Immunol"},{"issue":"1","key":"724_CR61","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1007\/s13311-016-0480-0","volume":"14","author":"BM Escribano","year":"2017","unstructured":"Escribano BM, Medina-Fernandez FJ, Aguilar-Luque M, Aguera E, Feijoo M, Garcia-Maceira FI, Lillo R, Vieyra-Reyes P, Giraldo AI, Luque E, et al. Lipopolysaccharide binding protein and oxidative stress in a multiple sclerosis model. Neurotherapeutics. 2017;14(1):199\u2013211. https:\/\/doi.org\/10.1007\/s13311-016-0480-0.","journal-title":"Neurotherapeutics"},{"issue":"8","key":"724_CR62","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s12276-018-0126-x","volume":"50","author":"C Chelakkot","year":"2018","unstructured":"Chelakkot C, Ghim J, Ryu SH. Mechanisms regulating intestinal barrier integrity and its pathological implications. Exp Mol Med. 2018;50(8):1\u20139. https:\/\/doi.org\/10.1038\/s12276-018-0126-x.","journal-title":"Exp Mol Med"},{"issue":"5","key":"724_CR63","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1007\/s00401-011-0883-2","volume":"122","author":"F Pfeiffer","year":"2011","unstructured":"Pfeiffer F, Schafer J, Lyck R, Makrides V, Brunner S, Schaeren-Wiemers N, Deutsch U, Engelhardt B. Claudin-1 induced sealing of blood-brain barrier tight junctions ameliorates chronic experimental autoimmune encephalomyelitis. Acta Neuropathol. 2011;122(5):601\u201314. https:\/\/doi.org\/10.1007\/s00401-011-0883-2.","journal-title":"Acta Neuropathol"},{"issue":"3","key":"724_CR64","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1093\/jnen\/63.3.223","volume":"63","author":"K Biernacki","year":"2004","unstructured":"Biernacki K, Prat A, Blain M, Antel JP. Regulation of cellular and molecular trafficking across human brain endothelial cells by Th1- and Th2-polarized lymphocytes. J Neuropathol Exp Neurol. 2004;63(3):223\u201332. https:\/\/doi.org\/10.1093\/jnen\/63.3.223.","journal-title":"J Neuropathol Exp Neurol"},{"issue":"4","key":"724_CR65","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1093\/jnen\/62.4.412","volume":"62","author":"R Seguin","year":"2003","unstructured":"Seguin R, Biernacki K, Rotondo RL, Prat A, Antel JP. Regulation and functional effects of monocyte migration across human brain-derived endothelial cells. J Neuropathol Exp Neurol. 2003;62(4):412\u20139. https:\/\/doi.org\/10.1093\/jnen\/62.4.412.","journal-title":"J Neuropathol Exp Neurol"},{"issue":"36","key":"724_CR66","doi-asserted-by":"publisher","first-page":"22402","DOI":"10.1073\/pnas.2011703117","volume":"117","author":"D Takewaki","year":"2020","unstructured":"Takewaki D, Suda W, Sato W, Takayasu L, Kumar N, Kimura K, Kaga N, Mizuno T, Miyake S, Hattori M, Yamamura T. Alterations of the gut ecological and functional microenvironment in different stages of multiple sclerosis. Proc Natl Acad Sci U S A. 2020;117(36):22402\u201312. https:\/\/doi.org\/10.1073\/pnas.2011703117.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"3","key":"724_CR67","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1111\/ane.13045","volume":"139","author":"P Melbye","year":"2019","unstructured":"Melbye P, Olsson A, Hansen TH, Sondergaard HB, Bang Oturai A. Short-chain fatty acids and gut microbiota in multiple sclerosis. Acta Neurol Scand. 2019;139(3):208\u201319. https:\/\/doi.org\/10.1111\/ane.13045.","journal-title":"Acta Neurol Scand"},{"key":"724_CR68","doi-asserted-by":"publisher","unstructured":"Park J, Wang Q, Wu Q, Mao-Draayer Y, Kim CH. Bidirectional regulatory potentials of short-chain fatty acids and their G-protein-coupled receptors in autoimmune neuroinflammation. Sci Rep-Uk. 2019;9:8837. ARTN 17511 https:\/\/doi.org\/10.1038\/s41598-019-54276-x.","DOI":"10.1038\/s41598-019-54276-x"},{"issue":"2","key":"724_CR69","doi-asserted-by":"publisher","first-page":"e0173032","DOI":"10.1371\/journal.pone.0173032","volume":"12","author":"M Mizuno","year":"2017","unstructured":"Mizuno M, Noto D, Kaga N, Chiba A, Miyake S. The dual role of short fatty acid chains in the pathogenesis of autoimmune disease models. PLoS ONE. 2017;12(2):e0173032. https:\/\/doi.org\/10.1371\/journal.pone.0173032.","journal-title":"PLoS ONE"},{"issue":"4","key":"724_CR70","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1016\/j.brs.2018.01.034","volume":"11","author":"Y Yang","year":"2018","unstructured":"Yang Y, Yang LY, Orban L, Cuylear D, Thompson J, Simon B, Yang Y. Non-invasive vagus nerve stimulation reduces blood-brain barrier disruption in a rat model of ischemic stroke. Brain Stimul. 2018;11(4):689\u201398. https:\/\/doi.org\/10.1016\/j.brs.2018.01.034.","journal-title":"Brain Stimul"},{"key":"724_CR71","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1016\/j.bbi.2025.01.006","volume":"125","author":"P Bianchimano","year":"2025","unstructured":"Bianchimano P, Leone P, Smith EM, Gutierrez-Vazquez C, Wind-Andersen E, Bongers G, Cristancho S, Weiner HL, Clemente JC, Tankou SK. Oral Vancomycin treatment alters levels of Indole derivatives and secondary bile acids modulating the expression of mTOR pathway genes in astrocytes during EAE. Brain Behav Immun. 2025;125:355\u201370. https:\/\/doi.org\/10.1016\/j.bbi.2025.01.006. From NLM Medline.","journal-title":"Brain Behav Immun"}],"container-title":["Fluids and Barriers of the CNS"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12987-025-00724-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12987-025-00724-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12987-025-00724-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T12:54:17Z","timestamp":1781614457000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12987-025-00724-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,7]]},"references-count":71,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["724"],"URL":"https:\/\/doi.org\/10.1186\/s12987-025-00724-y","relation":{},"ISSN":["2045-8118"],"issn-type":[{"value":"2045-8118","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,7]]},"assertion":[{"value":"21 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All mice experiments were officially approved by the ethical committee of the Faculty of Sciences, Ghent University (EC2022-059, EC2023-018).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"114"}}